![](/img/cover-not-exists.png)
A phase I dose-escalation study of the safety and pharmacokinetics of a tablet formulation of voxtalisib, a phosphoinositide 3-kinase inhibitor, in patients with solid tumors
Mehnert, Janice M., Edelman, Gerald, Stein, Mark, Camisa, Heather, Lager, Joanne, Dedieu, Jean-François, Ghuysen, Anne-Frédérique, Sharma, Jyoti, Liu, Li, LoRusso, Patricia M.Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-017-0467-7
Date:
April, 2017
File:
PDF, 491 KB
english, 2017